The new generation of molecular medicine is transforming the healthcare paradigm, emphasizing the integration of advanced molecular technologies into diagnostics and therapeutics. By bridging biology and chemistry with precision-targeted approaches, molecular medicines can now offer tailored solutions to complex diseases. Against this backdrop, our lab intends to employ a multidisciplinary approach that integrates immunotherapy, molecular imaging, and drug delivery strategies to unravel the complexities of neurological dysfunction. This research will target a broad spectrum of conditions, from aggressive brain cancers like glioblastoma to neurodegenerative diseases like Alzheimer's, advancing both scientific understanding and therapeutic interventions. Working at the interface of synthetic organometallic chemistry and chemical biology, the lab aims to translate fundamental molecular insights into clinically relevant applications.